The sudden resurgence of the virus is a rude jolt for a country that believed it had put the worst of the pandemic behind it
Listening to the lungs of a COVID patient on Jan. 16, 2021, at Homerton Hospital in London. Protection from two shots of AstraZeneca, the most widely used vaccine in Britain, drops from 88 percent after one month to 74 percent after four to five months, according to an analysis of a study by Tim Spector, a professor of genetic epidemiology at King’s College London; Image: Andrew Testa/The New York Times
For the past four months, Britain has run a grand epidemiological experiment, lifting virtually all coronavirus restrictions, even in the face of a high daily rate of infections. Its leaders justified the approach on the grounds that the country’s rapid rollout of vaccines had weakened the link between infection and serious illness.
Now, with cases, hospital admissions and deaths all rising again; the effect of vaccines beginning to wear off; and winter looming, Britain’s strategy of learning to live with the virus is coming under its stiffest test yet.
New cases surpassed 50,000 on Thursday, an 18% increase over the past week and the second time cases have broken that psychological barrier since July. The number of people admitted to hospitals rose 15.4% over the same period, reaching 959, while 115 people died of COVID-19, an increase of almost 11%.
“Everything is hitting us at once,” said Tim Spector, a professor of genetic epidemiology at King’s College London who has been leading a major study of COVID-19 symptoms. “My view is that we’re in a no man’s land.”
The sudden resurgence of the virus is a rude jolt for a country that believed it had put the worst of the pandemic behind it. After a remarkably successful vaccine deployment and a characteristically British resolve to get on with it, Britons have been brought up short, vexed by a virus that isn’t ready to relinquish its grip.
©2019 New York Times News Service